S1
Siren 101
Analyzing
Extracting target signal
Siren 101
Extracting target signal
Siren 101
Arcmira media summary
Browse Siren 101 reviews, demos & launch coverage — 2 indexed from Vincent Private Markets & Kingscrowd, updated Oct 2025.
The lead universal viral gene therapy asset developed by Siren.
The lead asset/virus being advanced for clinical trials in brain cancer.
Arcmira tracks 2 indexed media appearances or mentions for Siren 101, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "Smart Humans: Siren CEO Nicole Paulk on revolutionizing cancer treatment and the biotech market" with transcript-derived context and links when available.
Siren 101 is connected to Universal AAV Gene Therapy, Gene Therapy Innovation, Biotech Market Trends in Arcmira's media graph.
2
Mentions
210
Views
The trendline is visible, but the dated evidence behind Siren 101 is in the premium layer.
“The lead universal viral gene therapy asset developed by Siren.”
“The lead asset/virus being advanced for clinical trials in brain cancer.”